1Bagheri H, Damase-Michel C, Lapeyre-Mestre M, et al. A study of salivary secretion in Parkinson's disease. Clin Neuropharmacol, 19991 22(4): 213-5
2Proulx M, de Courval FP, Wiseman MA,et al. Salivary production in Parkinson's disease. Mov Disord, 20053 20(2):204-7
3Omar R. Tumilasci, M.G. Cersbsimo, Juan E. Belforte, et al. Quantitative study of salivary secretion ,in Parkinson's disease. Movement Disorders, 2006; 21(5): 660-667
4H uskic J, Paperniku A, H usic A,et al. Significantly reduced salivary nitric oxide synthesis in patients with Parkinson's disease. Bosn J Basic Med, 2005; 5(3): 86-9
5Persson M, Osterberg T, Granerus AK,et al, Influence of Parkinson's disease on oral health. Aeta Odontol Seand, 1992; 50(1): 37 -42
6Fukayo S. Dental status in outpatients with Parkinson's disease. Nippon Eiseigaku Zasshi, 2002;57(3): 585-90
7Fukayo S, Nonaka K, Shimizu T,et al. Oral health of patients with Parkinson's disease: faetors related to their better dental status. Tohoku J Exp Med, 2003;201(3): 171-9
8Friedman A, Potulska A. Botulinum toxin for treatment of parkinsonian sialorrhea. Neurol Neurochir Pol, 2001 ; 35 Suppl 3 : 23 - 7
9Mancini F, Zangaglia R, Cristina S, et al. Double-blind, placebocontrolled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism. Mov Disord, 2003;18(6): 685-8
10Marks L, Turner K, O'Sullivan J, et al. Drooling in Parkinson's disease: a novel speech and language therapy intervention. Int J Lang Commun Disord, 2001;36 Suppl: 282-7
